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Abstract
Background: Cardiovascular disease (CVD) is a significant cause of morbidity and mor-
tality	globally.	Obesity	is	an	important	CVD	risk	factor	and	is	increasing	in	prevalence.
Methods: In	this	study,	3829	men	and	5720	women	(35-65	years)	were	enrolled	as	
part	 of	 the	MASHAD	 cohort	 study.	 Four	 categories	 were	 identified	 according	 to	
body	mass	 index	 and	waist	 circumference	 that	 was	 defined	 by	 the	World	 Health	
Organization.	Logistic	regression	analysis	was	used	to	determine	the	adjusted	odds	
ratio	(OR)	for	the	occurrence	of	CVD,	and	Cox	regression	model	was	used	to	evaluate	
the association of obesity with CVD incidence.
Results: We	found	that	the	higher	risk	groups	defined	by	categories	of	adiposity	were	
significantly	related	to	a	higher	prevalence	of	a	high	serum	total	cholesterol	(TC),	and	
triglycerides	 (TG),	and	 lower	high-density	 lipoprotein	cholesterol	 (HDL),	and	higher	
fasting	blood	glucose	(FBG)	in	both	genders	and	a	higher	low-density	lipoprotein	cho-
lesterol	 (LDL)	 in	women	 (P	 <	 .001).	Additionally,	 a	 high	 percentage	of	 participants	
with	dyslipidemia,	high	LDL,	high	TC,	and	low	HDL	and	a	high	percentage	of	partici-
pants	with	metabolic	syndrome,	diabetes,	hypertension,	and	a	high	serum	TG	were	
observed across obesity categories (P < .001).	Moreover,	women	with	the	very	high	
degrees	of	obesity	had	a	greater	risk	of	CVD	(HR:	1.91,	95%	CI:	1.06-3.43,	P = .03).
Conclusion: Obesity	strongly	predicts	several	CVD	risk	factors.	Following	6	years	of	
follow-up,	in	individuals	within	increasing	degrees	of	obesity,	there	was	a	correspond-
ing	significant	increase	in	CVD	events,	rising	to	approximately	a	twofold	higher	risk	of	
cardiovascular events in women compared with men.
2 of 9  |     GHAZIZADEH Et Al.
1  | INTRODUC TION
In	the	last	two	decades,	the	progressive	increase	in	the	prevalence	
of	obesity	has	occurred	in	many	areas	of	the	world,	both	in	develop-
ing	and	developed	countries	such	as	Iran	and	the	United	States.1-4 
According	to	the	cardiovascular	diseases	project	 (MONICA),	 Iran	
has the highest prevalence of childhood obesity among countries 
presented	in	the	report	of	the	World	Health	Organization	(WHO).	
Over	 one	 billion	 adults	 worldwide	 are	 suffering	 from	 excess	
weight.	 Obesity	 is	 a	 multifactorial	 disorder,	 and	 environmental	
causes	 such	 as	 lifestyle,	 unhealthy	diets,	 and	physical	 inactivity,	
as	well	 as	 genetic	 causes,	 are	 risk	 factors	 for	excess	weight	 and	
obesity	which	 is	 associated	with	 several	 non-communicable	 dis-
eases	 including	 diabetes,	 arthritis,	 hypertension,	 hyperlipidemia,	
and cardiovascular diseases (CVD).1-7 CVD is a primary chronic 
non-communicable	 disease	 that	 can	 be	 the	 cause	 of	 disability,	
which is more critical in active ages.8	 Studies	 show	 that	 chronic	
diseases	are	responsible	for	50%	of	the	burden	of	total	disease	in	
middle-income	countries,	and	12%	of	this	percentage	was	related	
to CVD.8-10	CVD	mortality	is	related	to	the	degree	of	obesity,	and	
a	threefold	increased	risk	in	men	and	women	with	excess	weight	
and	obesity	has	been	reported	in	the	USA.11	Applying	body	mass	
index	 (BMI,	kg/m2)	as	a	marker	of	excess	body	fat	accumulation,	
studies	have	shown	either	null,	linear,	J-	or	U-shaped	associations	
with	mortality	 risk.4,5	 It	 has	 been	 reported	 that	 overweight	 and	
obesity	increase	the	risk	of	death	specifically	mortality	related	to	
CVD.	All-cause	mortality	decreased	in	subjects	aged	60	years	with	
BMI	of	20-25	kg/m2,	meanwhile	weight	loss	cannot	prevent	CVD	
events.12
It	 has	 been	 shown	 that	 there	 are	 gender-dependent	 car-
diometabolic	differences,	while	the	role	of	gender	in	the	severity	
of obesity is not apparent.13	Therefore,	we	conducted	this	study	
to investigate the predictive values of anthropometric indices for 
CVD	risk	factors	in	Iranian	men	and	women	with	different	degrees	
of obesity.
2  | MATERIAL S AND METHODS
2.1 | Study population
The population in this study comprised 3829 men with aged 
49.12 ± 8.37 years and 5720 women with an mean age of 
46.99	±	8.02	years	 that	were	enrolled	 from	the	Mashhad	stroke	
and	 heart	 atherosclerotic	 disorder	 (MASHAD)	 cohort	 study.	
MASHAD	 study	 aimed	 to	 identify	 the	 risk	 and	 incidence	of	 car-
diovascular events as described elsewhere.14 Those participants 
with missing data regarding anthropometric measurements and 
biochemical	factors	(n	=	155)	were	excluded,	and	finally,	9549	in-
dividuals	were	included	in	the	current	analysis.	Four	groups	were	
defined	according	to	body	mass	index	(BMI)	and	waist	circumfer-
ence	 in	 accordance	with	 the	World	Health	Organization	 (WHO)	
classification	for	obesity:	no	risk,	increased	risk,	high	risk,	and	very	
high	risk.
2.2 | Baseline assessments
In	 the	MASHAD	 study,	 biochemical	 parameters	 (including	 fasting	
blood	 glucose	 [FBG]	 and	 lipid	 profiles),	 demographic	 data	 (includ-
ing	educational	 level,	gender,	and	age)	and	medical	history	as	well	
as	 lifestyle	 information	 (including	 smoking	 habit),	 anthropometric	
data	 (including	waist	 circumference	 [WC],	body	mass	 index	 [BMI],	
weight,	and	height)	and	physical	activity	 (by	Self-declaration	form)	
were gathered by a nurse interview.15 The methods of biochemical 
measurements using an automated analyzer and blood pressure as-
sessments using a standard mercury sphygmomanometer are de-
scribed elsewhere.16 Participants with dyslipidemia were defined by 
lipid	profiles,	as	described	previously.17
We	 used	 the	 BMI	 categories	 as	 defined	 by	 the	World	 Health	
Organization	 (WHO)	 recommendations	 for	 obesity	 Table	 1.	 Also,	
the	 following	 four	 categories	 were	 used:	 underweight,	 normal,	
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K E Y W O R D S
cardiovascular	risk	factors,	obesity
BMI classification BMI (kg/m2) Waist circumference  
  Men	<	102	cm
Women < 88 cm
Men	>	102	cm
Women	>	88	cm
Underweight <18.5 No	increased	risk No	increased	risk
Normal 18.5-24.9 No	increased	risk No	increased	risk
Overweight 25-29.9 Increased	risk High	risk
Obesity 30-34.9
35-39.9
High	risk
Very	high	risk
Very	high	risk
Very	high	risk
Extreme	obesity ≥40 Very	high	risk Very	high	risk
Note: Obesity	categories	as	defined	by	World	Health	Organization	recommendations.
Abbreviations:	BMI,	body	mass	index.
TA B L E  1   Categories of obesity based 
on	combined	BMI	and	WC,	in	accordance	
with	the	NIH	Practical	guide	to	obesity18
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overweight,	obesity,	 and	extreme	obesity	 for	 the	current	analysis.	
According	 to	 the	WHO	 recommendations	 for	 obesity,	 BMI	 more	
than	 25	 kg/m2	 was	 defined	 as	 overweight,	 and	 BMI	 higher	 than	
30	kg/m2 was considered as obese. Based on the cutoff points of 
the	NIH	Practical	guide	to	obesity,	WC	>	102	cm	in	men	and	>88	cm	
in	women	were	considered	high.	The	combination	of	BMI	and	WC	
was	categorized	too,no	risk,	increased	risk,	high	risk,	and	very	high	
risk	according	to	WHO	guideline.	Having	higher	BMI	and	WC	values	
are	considered	as	a	higher	risk	for	developing	CVD	event	and	its	risk	
factors.18 Hypertension was diagnosed in individuals with systolic 
blood	pressure	at	or	above	140	mm	Hg	and,	or	diastolic	blood	pres-
sure	at	or	above	90	mm	Hg,	and	in	individuals	who	were	on	anti-hy-
pertension medication.
2.3 | Follow-up
The	 participants	 with	 CVD	 were	 approved	 at	 follow-up	 to	 assess	
medical	history	and	physical	test	by	an	expert	Cardiologist.	These	data	
were	collected	during	three	follow-up	periods;	a	total	of	768	subjects	
claimed	 to	 have	 a	 CVD	 event.	 Further	 assessments	 of	 participants	
were	performed,	including	a	history	of	myocardial	infarction	or	angina	
pectoris together with electrocardiographic evidence of a definite Q 
wave	using	the	Minnesota	Code;19,20	physical	examination,	and	a	de-
tailed	medical	history	taken	by	a	cardiologist	and	in	suspicious	cases,	
they	were	also	 investigated	using	echocardiography,	 stress	echocar-
diography,	 radioisotope,	 angiography,	 computed	 tomography	 (CT)	
angiography,	and	Exercise	Tolerance	Test	 (ETT)	at	a	complementary	
medical	examination,	if	the	cardiologist	suspected	to	a	test	of	partici-
pants	at	the	third	follow-up.	Finally,	the	diagnosis	was	made	according	
to	 the	consensus	decision	of	a	panel	of	experts.	Therefore,	235	pa-
tients were considered to have developed CVD including 120 subjects 
with	unstable	angina	(UA),	75	subjects	with	stable	angina	(SA),	and	40	
subjects	with	myocardial	infarction	(MI).
2.4 | Ethical issues
Informed	 consent	 was	 obtained	 from	 all	 subjects	 (were	 written)	
using	protocols	approved	by	the	Ethics	Committee	of	the	Mashhad	
University	of	Medical	Sciences.
2.5 | Statistical analysis
Data	were	expressed	as	mean	±	SD	(for	normally	distributed	data)	or	
median	and	inter-quartiles	range	(for	non-normally	distributed	data).	
Data	analyses	were	undertaken	using	SPSS	version	18.	It	has	been	
determined	 the	 normality	 of	 data	 using	 the	 Kolmogorov-Smirnov	
test.	Based	on	data	distribution	pattern,	Student's	t	test,	analysis	of	
variance	(ANOVA),	Mann-Whitney	U,	and	Kruskal-Wallis	tests	were	
used to analyze data in the groups. We used a logistic regression 
analysis	to	determine	the	unadjusted	and	adjusted	odds	ratio	 (OR)	
for	the	occurrence	of	CVD.	Cox	regression	model	was	used	to	evalu-
ate	the	association	of	obesity	categories	with	CVD	incidence.	A	P-
value of <.05 was considered as statistically significant.
3  | RESULTS
3.1 | Characteristics of participants
Anthropometric	 and	biochemical	 characteristics	of	participants	by	
NIH	Practical	guide	to	obesity	categories	in	men	and	women	are	de-
scribed	in	Tables	2	and	3.	Of	the	total	3834	participants,	1407,	506,	
and 491 individuals were classified for adiposity as at an increased 
risk,	high	risk,	and	very	high-risk	group	in	men,	respectively.	On	the	
other	hand,	of	the	total	5722	participants,	577,	1842,	and	2101	in-
dividuals	were	categorized	as	being	at	increased	risk,	high	risk,	and	
very	high	risk	in	the	female	group,	respectively.
Tables 2 and 3 show a significant incremental rise in level of 
serum	 lipid	profiles	 (TC,	TG,	LDL,	and	HDL),	FBG,	anthropometric	
factors	(BMI,	WC,	HC,	WHR,	WHtR,	and	MAC)	and	SBP,	DBP	with	
an increasing degree of obesity in men and women participants 
(P	<	 .001).	We	observed	that	very	high-risk	men	and	women	were	
significantly older than the subjects in other groups (P < .001).
According	to	Tables	2	and	3,	a	high	percentage	of	men	with	MetS,	
diabetes,	HTN,	and	high	TG	were	in	groups	of	very	high	risk,	high	risk,	
and	increased	risk	(%	Mets:	65,	53.80,	33.20,%	diabetes:	11.40,	10.30,	
8.90;	%	HTN:	38.70,	31.80,	24.60;	%	high	TG:	53,	46.40,	44.70,	 re-
spectively)	in	comparison	with	women	(%	Mets:	58.80,	47.50,	25.10;	%	
diabetes:	9.50,	9,	5.90;	%	HTN:	30.30,	24.20,	13.50;	%	high	TG:	40.30,	
32.80,	23.10,	respectively).	Moreover,	the	percentage	of	women	with	
dyslipidemia,	high	LDL,	high	TC,	and	low	HDL	were	higher	for	women	
across	risk	categories	compared	with	men	(%	women	with	dyslipidemia	
89.40,	85.40,	85.30;	high	LDL-C:	33.60,	30.60,	30.40;	high	TC:	39.90,	
36.60,	37.10;	and	low	HDL-C:	77.30,	73.30,	72.30	and	%	men	with	dys-
lipidemia:	89.40,	85.40,	85.30;	high	LDL-C:	33.60,	30.60,	30.40;	high	
TC:	39.90,	36.60,	37.10;	and	low	HDL-C:	60.30,	59.10,	60.80,	respec-
tively	in	groups	of	very	high	risk,	high	risk,	and	increased	risk,	respec-
tively).	There	was	no	statistically	significant	difference	between	LDL	
levels	in	the	risk	categories	in	men	(P	>	.05).
3.2 | Association of CVD risk factors with 
obesity categories
Participants	 at	 raised	CVD	 risk	were	 examined	 using	 the	multiple	
regression analysis to determine the predictive values of obesity 
categories	for	CVD	risk	factors	Table	4.	 In	model	1	(before	adjust-
ing	for	confounder	factors)	as	we	expected,	increased	risk,	high	risk,	
and	very	high-risk	men	compared	with	the	reference	group	(no	risk)	
had	significantly	higher	risk	of	diabetes	than	women	(OR:1.79,	2.10	
and	2.36	in	men	group	and	OR:	0.97,	1.53	and	1.62	in	women	group,	
respectively)	as	well	as	hypertension	(OR:1.65,	2.36	and	3.19	in	men	
group	and	OR:	1.06,	2.16	and	2.94	 in	women	group,	 respectively),	
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high	TC	 (OR:1.47,	1.44	and	1.66	 in	men	group	and	OR:	1.05,	1.60	
and	1.58	in	women	group,	respectively),	high	TG	(OR:	3.27,	3.51	and	
4.56	in	men	group	and	OR:	1.39,	2.26	and	3.13	in	women	group,	re-
spectively),	dyslipidemia	(OR:	2.46,	2.48	and	3.58	in	men	group	and	
OR:	1.34,	2.23	and	2.66	in	women	group,	respectively),	high	LDL-C	
(OR:	1.15,	1.16	and	1.34	in	men	group	and	OR:	0.88,	1.38	and	1.29	
in	women	group,	 respectively),	 and	MetS	 (OR:	8.98,	21	and	33.51	
in	men	group	and	OR:	1.19,	3.20	and	5.04	in	women	group,	respec-
tively),	while	 high-risk	women	had	 significantly	 higher	 risk	of	 high	
LDL-C	 in	 comparison	with	men	 (OR:	1.38	 and	1.16	 in	woman	and	
men,	respectively).
However,	after	the	data	in	Table	4	were	adjusted	for	confounding	
factors	including	age,	smoking	(ex-smoked	and	current	smoking),	and	
physical	activity	level,	we	found	similar	results	with	model	1	for	risk	
factors	 of	 diabetes,	 hypertension,	 high	 TG,	 high	 TC,	 dyslipidemia,	
and	MetS.	The	 results	demonstrated	 that	CVD	risk	 factors	have	a	
graded	linear	relationship	with	risk	categories,	before	and	after	ad-
justing for confounding factors.
In	 this	 regard,	 very	 high-risk	 participants	 had	 a	 significantly	
higher	 risk	 of	MetS	 in	 comparison	with	 reference	 group	 (No	 risk)	
(OR:	 26.95;	 95%	CI:	 19.83-36.61;	P:	 <.001	 and	OR:	 4.42;	 95%	CI:	
3.69-5.28;	P:	<.001	 in	men	and	women,	respectively),	dyslipidemia	
(OR:	2.84;	95%	CI:	2.06-3.92;	P:	<.001	and	OR:	1.91;	95%	CI:	1.50-
2.43; P:	<.001	in	men	and	women,	respectively),	diabetes	(OR:	1.90;	
95%	CI:	1.29-2.77;	P:	.001	and	OR:	1.45;	95%	CI:	1.07-1.98;	P: .018 
in	men	and	women,	respectively),	hypertension	(OR:	2.91;	95%	CI:	
2.28-3.71;	P:	 <.00	1	 and	OR:	2.92;	95%	CI:	2.36-3.61;	P: <.001 in 
men	 and	women,	 respectively),	 high	 TG	 (OR:	 3.83;	 95%	CI:	 3.04-
4.83; P:	<.00	1	and	OR:	2.60;	95%	CI:	2.15-3.15;	P: <.001 in men and 
women,	respectively),	and	high	TC	(OR:	1.53;	95%	CI:	1.22-1.91;	P: 
TA B L E  2  Characteristics	of	participants	based	on	the	NIH	Practical	guide	to	obesity	categories	in	men
 
Obesity categories
PNo risk Increased risk High risk Very high risk
Number,	n 1427 1405 506 491  
Age,	y 48.26 ± 8.61 48.61 ± 8.30 50.48 ± 8.34 49.16 ± 8.24 <.001
BMI,	kg/m2 22.21 ± 2.09 27.15 ± 1.33 29.19 ± 1.96 33.03 ± 2.51 <.001
WC,	cm 84.76 ± 8.12 93.82 ± 5.69 102.30 ± 6.64 109.95 ± 6.33 <.001
HC,	cm 95.17 ± 5.68 101.42 ± 5.24 105.50 ± 5.27 112.46 ± 6.15 <.001
WHR 0.89 ± 0.07 0.93 ± 0.06 0.97 ± 0.06 0.98 ± 0.05 <.001
WHtR 0.50 ± 4.75 0.56 ± 3.64 0.61 ± 4.03 0.65 ± 4.31 <.001
MAC,	cm 27.99 ± 3.58 30.69 ± 3.53 31.77 ± 2.42 33.87 ± 3.40 <.001
SBP,	mm	Hg 117.95 ± 16.10 122.54 ± 16.36 127.03 ± 17.10 129.34 ± 18.51 <.001
DBP,	mm	Hg 80 ± 10.25 80.46 ± 10.14 83.15 ± 10.57 84.43 ± 10.56 <.001
TC,	mg/dL 180.36 ± 37.68 190.19 ± 36.21 190.26 ± 40.11 192.10 ± 38.27 <.001
TG,	mg/dL 98	(72,	137) 138.50	(97,	196) 144	(102,	197.25) 153	(114,	214) <.001
LDL-C,	mg/dL 112.42 ± 33.24 114.14 ± 34.15 113.95 ± 37.55 114.32 ± 35.72 .521
HDL-C,	mg/dL 41.60 ± 9.52 38.92 ± 8.91 38.93 ± 8.41 38.54 ± 9.47 <.001
FBG,	mg/dL 86.46 ± 34.21 91.54 ± 34.59 95.59 ± 38.40 96.57 ± 41.54 <.001
CVD	risk	factors
Prevalence,	%
Diabetes 5.20 8.90 10.30 11.40 <.001
Hypertension 16.50 24.60 31.80 38.70 <.001
High TC 28.60 37.10 36.60 39.90 <.001
High TG 19.80 44.70 46.40 53 <.001
High	LDL-C 27.50 30.40 30.60 33.60 .057
Low	HDL-C 46.40 60.80 59.10 60.30 <.001
Dyslipidemia 70.20 85.30 85.40 89.40 <.001
MetS 5.20 33.20 53.80 65 <.001
Note: Hypertension	was	defined	as	systolic	blood	pressure	≥140	mm	Hg,	diastolic	blood	pressure	≥90	mm	Hg.	Diabetes	was	defined	as	fasting	blood	
glucose	≥126	mg/dL.	Dyslipidemia	was	defined	as	total	cholesterol	≥200,	or	triglycerides	≥150,	or	low-density	lipoprotein	cholesterol	(LDL-C)	≥130,	
or	high-density	lipoprotein	cholesterol	(HDL-C)	<40	(for	men)	and	HDL-C	<	50	(for	women).
Abbreviations:	BMI,	body	mass	index;	DBP,	diastolic	blood	pressure;	HC,	hip	circumference;	HDL-C,	high-density	lipoprotein	cholesterol;	LDL-C,	low-
density	lipoprotein	cholesterol;	MAC,	mid-upper	arm	circumference;	MetS,	metabolic	syndrome;	SBP,	systolic	blood	pressure;	TC,	total	cholesterol;	
TG,	triglyceride;	WC,	waist	circumference;	WHR,	waist-to-hip	ratio;	WHtR,	waist-to-height	ratio.
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<.001	and	OR:	1.58;	95%	CI:	1.33-1.86;	P	<	.001	in	men	and	women,	
respectively).
After	 adjusting	 for	 confounding	 factors,	we	did	not	 find	 a	 sig-
nificant	association	between	high	LDL-C	and	degree	of	risk	in	men	
group (P: .09) while this association was significant for female group 
(P:	 .006).	Moreover,	on	the	basis	of	models	1	and	2,	very	high-risk	
participants	in	comparison	with	the	reference	group	(no	risk)	had	the	
highest	risk	significantly	for	low	HDL-C	in	men	(odds	ratio:	1.43;	95%	
CI:	1.15-1.78;	P:	 .001)	and	women	 (odds	 ratio:	1.36;	95%	CI:	1.11-
1.54; P:	.001),	respectively.
According	 to	 Table	 5	 and	 after	 adjusting	 for	 confounding	 fac-
tors,	we	demonstrated	that	women	with	a	very	high	risk	of	obesity	
in	 comparison	with	 the	 reference	 group	 (no	 risk)	 had	 significantly	
increased	the	risk	of	CVD	(HR:	1.91,95%	CI:	1.06-3.43;	P: .03) while 
these association were not significant among men.
4  | DISCUSSION
In	the	present	study,	after	6	years	of	follow-up,	CVD	was	reported	in	
235 participants of the study population including 120 cases of un-
stable	angina,	75	cases	of	stable	angina,	and	40	cases	of	myocardial	
infarction.	Also,	we	found	a	significant	direct	association	between	
extreme	obesity,	including	both	high	BMI	and	WC,	and	CVD	events	
only	in	women.	However,	our	previous	studies	showed	an	associa-
tion between genetic and environmental factors with cardiometa-
bolic	risk	factors	such	as	obesity	and	metabolic	syndrome.21-24	Sertic	
and colleagues reported an association between anthropometric 
factors	 including	weight,	BMI,	and	waist-hip	ratio	 (WHR)	with	diet	
type.	Additionally,	 these	 results	 showed	 that	 several	 genetic	 vari-
ants	(ESR-1,	LPL,	and	APO	E)	could	be	considered	as	predictive	ge-
netic	risk	factors	for	obesity-related	metabolic	disorders	in	healthy	
TA B L E  3  Characteristics	of	participants	by	NIH	Practical	guide	to	obesity	categories	in	women
 
Obesity categories
P-valueNo risk Increased risk High risk Very high risk
Number,	n 1202 577 1840 2101  
Age,	y 46.76 ± 8.36 45.15 ± 7.87 47.77 ± 7.95 48.29 ± 7.90 <.001
BMI,	kg/m2 22.64 ± 1.92 27.06 ± 1.38 28.01 ± 1.66 33.78 ± 3.29 <.001
WC,	cm 84.72 ± 9.59 81.62 ± 4.49 96.71 ± 7.16 106.12 ± 9.85 <.001
HC,	cm 95.43 ± 6.05 100.07 ± 5.67 104.19 ± 5.20 113.86 ± 8.27 <.001
WHR 0.89 ± 0.08 0.82 ± 0.06 0.93 ± 0.07 0.93 ± 0.07 <.001
WHtR 0.54 ± 6.23 0.53 ± 3.38 0.62 ± 4.69 0.69 ± 6.38 <.001
MAC,	cm 27.37 ± 2.93 28.98 ± 3.49 30.54 ± 2.94 33.28 ± 3.61 <.001
SBP,	mm	Hg 114.79 ± 17.12 115.65 ± 26.34 122.35 ± 19.28 125.75 ± 19.55 <.001
DBP,	mm	Hg 74.57 ± 13.01 75.08 ± 10.32 79.16 ± 12.99 81.15 ± 11.39 <.001
TC,	mg/dL 186.76 ± 39.24 189.11 ± 36.38 196.20 ± 39.15 198.19 ± 39.88 <.001
TG,	mg/dL 92	(68,	132) 106	(74,	145) 118	(86,	168) 132	(97,	182) <.001
LDL-C,	mg/dL 114.90 ± 35.46 113.08 ± 32.95 121.23 ± 35.42 120.19 ± 35.95 <.001
HDL-C,	mg/dL 47.25 ± 10.52 44.99 ± 10.12 44.76 ± 9.82 43.63 ± 9.22 <.001
FBG,	mg/dL 87.68 ± 40.07 87.47 ± 34.57 93.52 ± 40.72 93.75 ± 35.29 <.001
CVD	risk	factors
Prevalence,	%
Diabetes 6.10 5.90 9 9.50 .001
Hypertension 12.90 13.50 24.20 30.30 <.001
High TC 33.80 34.80 44.90 44.60 <.001
High TG 17.70 23.10 32.80 40.30 <.001
High	LDL-C 30.70 28.10 37.90 36.40 <.001
Low	HDL-C 64.90 72.30 73.30 77.30 <.001
Dyslipidemia 81.60 85.60 90.80 92.20 <.001
MetS 22 25.10 47.50 58.80 <.001
Note: Hypertension	was	defined	as	systolic	blood	pressure	≥	140	mm	Hg,	diastolic	blood	pressure	≥	90	mm	Hg.	Diabetes	was	defined	as	fasting	
blood	glucose	≥	126	mg/dL.	Dyslipidemia	was	defined	as	total	cholesterol	≥	200,	or	triglycerides	≥	150,	or	low-density	lipoprotein	cholesterol	(LDL-
C)	≥	130,	or	high-density	lipoprotein	cholesterol	(HDL-C)	<	40	(for	men)	and	HDL-C	<	50	(for	women).
Abbreviations:	BMI,	body	mass	index;	DBP,	diastolic	blood	pressure;	HC,	hip	circumference;	HDL-C,	high-density	lipoprotein	cholesterol;	LDL-C,	low-
density	lipoprotein	cholesterol;	MAC,	mid-upper	arm	circumference;	MetS,	metabolic	syndrome;	SBP,	systolic	blood	pressure;	TC,	total	cholesterol;	
TG,	triglyceride;	WC,	waist	circumference;	WHR,	waist-to-hip	ratio;	WHtR,	waist-to-height	ratio.
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TA B L E  4  Odds	ratio	of	CVD	risk	factors	based	on	obesity	categories
 
Men Women
Model 1 Model 2 Model 1 Model 2
Diabetes
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 1.79	(1.33-2.41) 1.58	(1.16-2.15) 0.97	(0.64-1.47) 0.97	(0.64-1.48)
High	risk 2.10	(1.45-3.04) 1.70	(1.15-2.51) 1.53	(1.15-2.04) 1.44	(1.07-1.93)
Very	high	risk 2.36	(1.64-3.39) 1.90	(1.29-2.77) 1.62	(1.23-2.14) 1.45	(1.07-1.98)
P-value <.001 .001 .001 .018
Hypertension
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 1.65	(1.37-1.99) 1.56	(1.28-1.89) 1.06	(0.79-1.41) 1.08	(0.80-1.44)
High	risk 2.36	(1.87-2.98) 2.14	(1.68-2.73) 2.16	(1.77-2.63) 2.11	(1.72-2.59)
Very	high	risk 3.19	(2.54-4.02) 2.91	(2.28-3.71) 2.94	(2.42-3.56) 2.92	(2.36-3.61)
P-value <.001 <.001 <.001 <.001
High TC
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 1.47	(1.26-1.72) 1.40	(1.19-1.65) 1.05	(0.85-1.29) 1.06	(0.86-1.30)
High	risk 1.44	(1.16-1.78) 1.34	(1.07-1.67) 1.60	(1.37-1.86) 1.58	(1.35-1.85)
Very	high	risk 1.66	(1.34-2.05) 1.53	(1.22-1.91) 1.58	(1.36-1.83) 1.58	(1.33-1.86)
P-value <.001 <.001 <.001 <.001
High TG
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 3.27	(2.77-3.87) 2.99	(2.51-3.55) 1.39	(1.09-1.77) 1.34	(1.05-1.71)
High	risk 3.51	(2.83-4.37) 3.03	(2.41-3.80) 2.26	(1.90-2.70) 2.07	(1.73-2.48)
Very	high	risk 4.56	(3.66-5.68) 3.83	(3.04-4.83) 3.13	(2.64-3.72) 2.60	(2.15-3.15)
P-value <.001 <.001 <.001 <.001
High	LDL-C
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 1.15	(0.98-1.36) 1.10	(0.93-1.30) 0.88	(0.71-1.10) 0.88	(0.71-1.10)
High	risk 1.16	(0.93-1.45) 1.07	(0.85-1.35) 1.38	(1.18-1.61) 1.35	(1.15-1.59)
Very	high	risk 1.34	(1.07-1.66) 1.22	(0.97-1.54) 1.29	(1.11-1.50) 1.27	(1.07-1.50)
P-value .010 .091 .001 .006
Low	HDL-C
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 1.79	(1.55-2.08) 1.62	(1.38-1.89) 1.41	(1.13-1.75) 1.34	(1.08-1.67)
High	risk 1.67	(1.36-2.05) 1.40	(1.13-1.74) 1.48	(1.27-	1.74) 1.31	(1.11-1.54)
Very	high	risk 1.76	(1.43-2.16) 1.43	(1.15-1.78) 1.84	(1.57-2.15) 1.36	(1.11-1.54)
P-value <.001 .001 <.001 .001
Dyslipidemia
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 2.46	(2.04-2.96) 2.19	(1.81-2.66) 1.34	(1.02-1.76) 1.28	(0.97-1.69)
High	risk 2.48	(1.89-3.25) 2.02	(1.53-2.68) 2.23	(1.80-2.77) 1.91	(1.53-2.38)
Very	high	risk 3.58	(2.63-4.88) 2.84	(2.06-3.92) 2.66 (2.14 (3.30) 1.91	(1.50-2.43)
P-value <.001 <.001 <.001 <.001
MetS
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
(Continues)
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adults.25 We also found that adherence to western pattern was as-
sociated	with	higher	BMI.26,27
However,	there	are	several	conflicting	results	in	previous	inves-
tigations. Two prospective studies have shown that the association 
of	 BMI	 and	 coronary	 heart	 disease	 (CHD)	 is	 not	 different	 among	
males	 and	 females,	 though	 higher	 BMI	 significantly	 increased	 the	
risk	of	stroke	among	males.28,29	Also,	in	another	study	a	higher	BMI	
was found among CVD patients compared to healthy individuals.30 
According	to	the	EUROASPIRE	III	study,	obesity	is	a	more	common	
risk	 factor,	with	35%	prevalence	 rate	 in	CVD	patients.	The	preva-
lence	of	central	obesity	as	a	common	risk	factor	of	metabolic	disor-
ders	was	present	 in	53%.	This	prevalence	is	higher	 in	women	with	
CHD	than	men	with	the	prevalence	of	an	obesity	overall	of	45%.31 
Several	 studies	 similar	 results	 have	 presented	 in	 CVD	 patients	 in	
Europe	 and	 throughout	 the	world.32	 However,	 in	 a	 cohort	 design	
study	among	13307	German	participants	aged	25-74	years,	 it	was	
found	that	body	adiposity	index	(BAI)	and	WHtR	of	males	and	WC	
and	WHR	of	females	were	associated	with	increased	risk	of	all-cause	
and CVD mortality.33	Fat	distribution	differences	could	explain	the	
difference	of	cardiovascular	disease	risk	among	men	and	women,	so	
that	waist-to-height	ratio	(WHtR)	among	males,	and	BMI	among	fe-
males are the best anthropometric indicators of arterial stiffness as 
an	independent	cardiovascular	risk	factor.34
We have found that obesity categories could predict the pres-
ence	of	many	CVD	risk	factors	in	this	study.	We	demonstrated	that	
increased obesity categories were significantly correlated with the 
greater	prevalence	of	higher	 serum	 levels	of	TC,	higher	TG,	 lower	
HDL,	and	higher	FBG	in	both	gender	and	higher	LDL	in	the	only	fe-
male.	Furthermore,	we	showed	that	there	was	a	significant	positive	
association	between	risk	elevation	in	obesity	categories	and	a	higher	
risk	of	diabetes,	hypertension,	dyslipidemia,	and	MetS	in	both	male	
patient	and	female	patient.	Moreover,	we	found	a	higher	risk	of	low	
HDL	 and	 increased	 TC,	 TG,	 and	 LDL	 level	 (only	 in	 female)	 across	
obesity	categories.	In	a	recent	population-based	study,	these	signif-
icant	associations	were	not	 found	 for	 raised	TC,	TG	and	LDL,	and	
low	HDL.35	In	the	HERMES	study,	the	relationship	between	serum	
lipid profile and severity of obesity was investigated in obese pa-
tients.	The	results	 for	TG	and	HDL	were	significant.	However,	 the	
results	 for	TC	and	LDL	 showed	an	 insignificant	 relationship.36 We 
found that the obesity categories in men were associated with a 
significantly	higher	risk	of	 incidence	of	MetS	compared	with	these	
categories	 in	female	patients.	 In	contrast,	 in	a	study	conducted	by	
Yin	et	al	although	an	increase	in	risk	severity	of	obesity	categories	
was	associated	with	a	higher	risk	of	incidence	of	MetS,	the	odds	ratio	
was somewhat similar in men and women.35	On	the	other	hand,	the	
OR	of	MetS	in	our	study	was	far	higher	in	male-related	obesity	cat-
egories	in	comparison	with	the	study	of	Yin	et	al	(OR:	8,	~17,	~27	vs	
OR:	~2,	~3,	~8).35
4.1 | Strength and limitations
To	the	best	of	our	knowledge,	the	present	study	is	the	first	study	indi-
cating	that	obesity	categories	can	predict	the	risk	of	CVD	outcomes	in	
 
Men Women
Model 1 Model 2 Model 1 Model 2
Increased	risk 8.98	(6.94-11.61) 8	(6.15-10.40) 1.19	(0.94-1.50) 1.17	(0.93-1.48)
High	risk 21	(15.70-28.09) 17.42	(12.92-23.49) 3.20	(2.71-3.77) 2.99	(2.52-3.53)
Very	high	risk 33.51	(24.89-45.11) 26.95	(19.83-36.61) 5.04	(4.29-5.93) 4.42	(3.69-5.28)
P-value <.001 <.001 <.001 <.001
Note: Model	1,	unadjusted;	Model	2,	association	adjusted	for	age	category	(35-44,	45-54,	55-65),	smoking	(ex-smoked	and	current	smoking)	and	
physical activity level.
Abbreviations:	HDL-C,	high-density	lipoprotein	cholesterol;	LDL-C,	low-density	lipoprotein	cholesterol;	MetS,	metabolic	syndrome;	TC,	total	
cholesterol;	TG,	triglyceride.
TA B L E  4   (Continued)
 
Men Women
Model 1 Model 2 Model 1 Model 2
No	risk 1 (reference) 1 (reference) 1 (reference) 1 (reference)
Increased	risk 1.08	(0.66-1.74) 1.02	(0.62-1.67) 0.45	(0.15-1.34) 0.47	(0.16-1.39)
High	risk 1.87	(1.08-3.23) 1.65	(0.92-2.94) 1.12	(0.63-2) 1.07	(0.59-1.94)
Very	high	risk 1.65	(0.92-2.93) 1.44	(0.78-2.65) 1.91	(1.13-3.24) 1.91	(1.06-3.43)
P-value .090 .242 .016 .030
Note: Model	1,	unadjusted;	Model	2,	association	adjusted	for	age	category	(35-44,	45-54,	55-65),	
smoking	(ex-smoked	and	current	smoking)	and	physical	activity	level.	A	P-value	of	<	.05	was	
considered as statistically significant and the bold format.
TA B L E  5   Hazard ratio (HR) of 
cardiovascular disease events according to 
obesity categories
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an	Iranian	population.	The	data	used	in	the	present	study	as	a	cross-sec-
tional	has	been	extracted	from	a	large	cohort	study	which	has	been	in-
cluded	individuals	aged	35	to	65	years.	Despite	the	mentioned	strength,	
this study may also have some limitations. The present study has only 
evaluated	a	population	in	Mashhad	city,	and	further	studies	can	be	con-
ducted	on	a	cohort	population	from	more	than	one	city	in	Iran.
4.2 | Conclusion
According	 to	 the	 results	 of	 the	 present	 study,	 obesity	 catego-
ries	 can	 strongly	predict	 the	presence	of	 several	CVD	 risk	 factors.	
Furthermore,	 our	 result	 suggested	 that	 increased	 obesity	 catego-
ries were significantly correlated with a greater prevalence of higher 
serum	levels	of	TC,	higher	TG,	lower	HDL,	and	higher	FBG.	Our	find-
ings	revealed	that	after	6	years	follow-up,	step-by-step	increased	obe-
sity	categories	were	significantly	associated	with	up	to	approximately	
twofold	 higher	 risk	 of	 cardiovascular	 events	 in	 the	 female	 gender.	
In	addition	to	the	mentioned	strength	and	limitations	in	the	present	
study,	these	findings	need	more	investigations	for	confirmation.
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